Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: A Children’s Oncology Group (COG) report

The ANHL01P1 trial was undertaken to determine pharmacokinetics and safety following the addition of rituximab to French-American-British/ /Lymphome Malins de Burkitt (FAB/LMB96) chemotherapy in 41 children and adolescents with Stage III/IV mature B-cell lymphoma/leukaemia. Patients received rituxim...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Barth, Matthew J., Goldman, Stanton, Smith, Lynette, Perkins, Sherrie, Shiramizu, Bruce, Gross, Thomas G., Harrison, Lauren, Sanger, Warren, Geyer, Mark B., Giulino-Roth, Lisa, Cairo, Mitchell S.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3745786/
https://ncbi.nlm.nih.gov/pubmed/23802659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12434
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים